European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies

Clinical trial NCT05043506 · COMPLETED

Trial details

NCT number: NCT05043506
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2022-02-08
Primary completion: 2023-11-02
Enrollment: 1939

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.